NASDAQ$NVAX
Novavax Inc · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
Announced fourth quarter and full year 2020 financial results and operational highlights.
Novavax reported a net loss of $177.6 million, or $2.70 per share, for the fourth quarter of 2020. Novavax revenue in the fourth quarter of 2020 was $279.7 million.
- Novavax continues to make significant strides towards bringing NVX-CoV2373, their COVID-19 vaccine candidate, to market.
- NVX-CoV2373 offers a highly unique profile, including the ability to ship and store the vaccine at traditional refrigerated temperatures.
- Novavax has secured agreements for the delivery of approximately 300 million doses of NVX-CoV2373.
- Novavax is partnering with the Serum Institute of India to jointly supply 1.1 billion doses of NVX-CoV2373 to Gavi through the COVAX Facility.
Headline financials
Revenue & EPS history
Novavax · Revenue · Quarterly
$277M
Revenue by segment
Novavax · $2.23M total across 1 segment · Q3 2023
- Product sales$2.23M—100.0%
Forward guidance
Novavax cautions that these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such statements.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2020
+2.5%
Avg return
Earnings day
+5.0%
Avg return
5 days after
+11.8%
Avg return
30 days after
36%
23 / 64 earnings
Positive
+193.3%
Q1 2024
Best reaction
-33.2%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +15.6% | +17.3% | +17.0% | |
| Q4 2025 | +0.5% | -0.4% | -11.3% | |
| Q3 2025 | -3.0% | -3.3% | -10.1% | |
| Q1 2025 | +11.6% | +4.0% | +25.2% | |
| Q4 2024 | -3.6% | +4.9% | -4.4% | |
| Q3 2024 | -13.8% | -18.8% | +0.1% | |
| Q2 2024 | +8.3% | +13.5% | +8.6% | |
| Q1 2024 | +193.3% | +188.6% | +306.5% | |
| Q4 2023 | -17.9% | -8.8% | -20.6% | |
| Q3 2023 | -8.2% | -8.2% | -18.1% | |
| Q2 2023 | -5.3% | -2.1% | +21.7% | |
| Q1 2023 | +20.7% | +13.4% | +3.2% | |
| Q4 2022 | -20.9% | -11.3% | -24.0% | |
| Q3 2022 | -4.1% | +28.9% | -10.9% | |
| Q2 2022 | -33.2% | -31.2% | -49.2% | |
| Q1 2022 | -6.0% | -9.4% | -12.5% | |
| Q4 2021 | +2.6% | -12.1% | -8.4% | |
| Q3 2021 | -18.4% | -13.3% | -17.8% | |
| Q2 2021 | -15.2% | +2.9% | +12.4% | |
| Q1 2021 | -21.5% | -25.2% | +19.1% | |
| Q4 2020 | -10.9% | -24.4% | -21.6% | |
| Q3 2020 | -12.4% | +7.5% | +28.2% | |
| Q2 2020 | -12.2% | -14.0% | -46.7% | |
| Q1 2020 | +112.6% | +132.9% | +140.0% | |
| Q4 2019 | -12.8% | -35.1% | +60.1% | |
| Q3 2019 | +3.8% | -6.3% | -1.6% | |
| Q2 2019 | -8.2% | -15.5% | +15.5% | |
| Q1 2019 | -7.8% | -21.6% | -44.3% | |
| Q4 2018 | +7.8% | +5.9% | +3.9% | |
| Q3 2018 | -3.7% | -10.5% | +7.3% | |
| Q2 2018 | +22.5% | +13.3% | +24.2% | |
| Q1 2018 | -1.2% | +4.3% | -1.2% | |
| Q4 2017 | -4.2% | -2.8% | -15.3% | |
| Q3 2017 | +0.9% | +0.0% | +24.8% | |
| Q2 2017 | +3.1% | +4.2% | +22.9% | |
| Q1 2017 | +14.9% | +35.1% | +43.2% | |
| Q4 2016 | +9.4% | +6.5% | -7.2% | |
| Q3 2016 | -3.4% | -6.9% | +0.7% | |
| Q2 2016 | -9.2% | -6.4% | -0.3% | |
| Q1 2016 | -8.9% | — | — | |
| Q4 2015 | -0.2% | — | — | |
| Q3 2015 | -12.2% | — | — | |
| Q2 2015 | +28.3% | — | — | |
| Q1 2015 | +4.4% | — | — | |
| Q4 2014 | -1.9% | — | — | |
| Q3 2014 | -7.2% | — | — | |
| Q2 2014 | -5.0% | — | — | |
| Q1 2014 | -7.1% | — | — | |
| Q4 2013 | -0.8% | — | — | |
| Q3 2013 | +3.2% | — | — | |
| Q2 2013 | -10.8% | — | — | |
| Q1 2013 | -8.9% | — | — | |
| Q4 2012 | -0.5% | — | — | |
| Q3 2012 | -1.8% | — | — | |
| Q2 2012 | +0.5% | — | — | |
| Q1 2012 | -5.7% | — | — | |
| Q4 2011 | +0.0% | — | — | |
| Q3 2011 | +0.0% | — | — | |
| Q2 2011 | +5.9% | — | — | |
| Q1 2011 | +0.4% | — | — | |
| Q4 2010 | +0.0% | — | — | |
| Q3 2010 | +1.3% | — | — | |
| Q2 2010 | -1.3% | — | — | |
| Q1 2010 | +14.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro